CI Investments Inc’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-827
| Closed | -$228K | – | 680 |
|
|
2025
Q4 | $228K | Sell |
827
-462
| -36% | -$126K | ﹤0.01% | 610 |
|
|
2025
Q3 | $338K | Sell |
1,289
-463
| -26% | -$113K | ﹤0.01% | 587 |
|
|
2025
Q2 | $383K | Sell |
1,752
-57
| -3% | -$12.2K | ﹤0.01% | 577 |
|
|
2025
Q1 | $405K | Sell |
1,809
-12,463
| -87% | -$3.43M | ﹤0.01% | 569 |
|
|
2024
Q4 | $4.67M | Buy |
14,272
+12,090
| +554% | +$3.8M | 0.02% | 308 |
|
|
2024
Q3 | $655K | Sell |
2,182
-110
| -5% | -$33.7K | ﹤0.01% | 454 |
|
|
2024
Q2 | $755K | Sell |
2,292
-158
| -6% | -$55.8K | ﹤0.01% | 422 |
|
|
2024
Q1 | $969K | Buy |
2,450
+497
| +25% | +$184K | ﹤0.01% | 392 |
|
|
2023
Q4 | $688K | Sell |
1,953
-540
| -22% | -$191K | ﹤0.01% | 401 |
|
|
2023
Q3 | $935K | Buy |
2,493
+618
| +33% | +$239K | 0.01% | 367 |
|
|
2023
Q2 | $717K | Buy |
1,875
+806
| +75% | +$288K | ﹤0.01% | 400 |
|
|
2023
Q1 | $370K | Buy |
1,069
+517
| +94% | +$151K | ﹤0.01% | 489 |
|
|
2022
Q4 | $130K | Buy |
552
+157
| +40% | +$37.2K | ﹤0.01% | 689 |
|
|
2022
Q3 | $97K | Sell |
395
-26
| -6% | -$7.92K | ﹤0.01% | 709 |
|
|
2022
Q2 | $127K | Sell |
421
-84
| -17% | -$27.3K | ﹤0.01% | 680 |
|
|
2022
Q1 | $207K | Sell |
505
-255
| -34% | -$99.8K | ﹤0.01% | 696 |
|
|
2021
Q4 | $356K | Sell |
760
-69
| -8% | -$29.7K | ﹤0.01% | 659 |
|
|
2021
Q3 | $352K | Buy |
829
+320
| +63% | +$135K | ﹤0.01% | 659 |
|
|
2021
Q2 | $183K | Buy |
509
+66
| +15% | +$21.8K | ﹤0.01% | 754 |
|
|
2021
Q1 | $125K | Sell |
443
-113
| -20% | -$32.3K | ﹤0.01% | 728 |
|
|
2020
Q4 | $158K | Sell |
556
-804
| -59% | -$226K | ﹤0.01% | 684 |
|
|
2020
Q3 | $374K | Buy |
+1,360
| New | +$360K | ﹤0.01% | 462 |
|
|
2019
Q4 | – | Sell |
-3,549
| Closed | -$503K | – | 644 |
|
|
2019
Q3 | $503K | Buy |
+3,549
| New | +$489K | ﹤0.01% | 486 |
|
Other funds holding WST
VCM
VPM
GIM
